MDMA-Assisted Therapy for PTSD: Neuroplastic Change or Psychotherapeutic Catalyst?
Translation The University of Toledo Journal of Medical Sciences February 17, 2026 Amy Hooper, Evelyn K. Lambe
MDMA-assisted psychotherapy shows promise for PTSD, especially when standard treatments like SSRIs and trauma-focused cognitive behavioral therapy have failed. A review of evidence from human and rodent studies examines two main explanations for its effects: a neurobiological model, where MDMA reduces amygdala reactivity, boosts hippocampal connectivity, and alters serotonin and oxytocin signaling to aid fear extinction, memory reconsolidation, and neuroplasticity; and a relational model, where MDMA's prosocial and empathogenic qualities strengthen the therapeutic alliance and patient suggestibility. Rather than being mutually exclusive, these processes likely work together, with MDMA creating a "window of emotional safety" that enables both neurobiological and interpersonal healing. Understanding this dual action is key to refining treatment protocols and therapist training.